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The phosphodiesterase 4 (PDE4) family, which specifically hydrolyzes intracellular cAMP, is 
composed by four isozymes (PDE4A, PDE4B, PDE4C and PDE4D) encoded by different gene 
loci, and each of them produces several mRNAs by alternative splicing (Houslay et al., 1998). 
These isozymes and their splice variants are widely expressed in many tissues including the 
brain (Pérez-Torres et al., 2000; McPhee et al., 2001; Miró et al., 2002; D'Sa et al., 2005). The 
different knock out mice for PDE4B and PDE4D genes present unique phenotypes, (Jin et al., 
1999; Jin and Conti, 2002; Jin et al., 2005), which suggests different functions for these 
isozymes. 
The majority of studies into PDE4 subtype distribution have focused upon inflammatory cells 
(Engels et al., 1994; Uhlig et al., 1997; Gantner et al., 1998). PDE4A, PDE4B and PDE4D, are 
found to some extent in different inflammatory cell types, where they could be important 
regulators of inflammatory processes. Selective inhibitors of PDE4s have been suggested as 
therapies for the treatment of several human diseases (Menniti et al., 2006), predominantly 
disorders of the immune and inflammatory systems (Teixeira et al., 1997) or disorders of the 
central nervous system, such as, depression (O'Donnell and Zhang, 2004) or Alzheimer's 
disease (McGeer and McGeer, 1995).  
The lipopolysaccharide (LPS) is a potent inflammatory agent that has been used to 
characterize the acute inflammatory process in the brain (Breder et al., 1994; Breder and Saper, 
1996). The efficacy of PDE4 inhibitors in inflammation models is remarkable and includes 
inhibition of LPS-induced increment in serum levels of tumour necrosis factor-α (TNF-α) in liver 
injury, lung injury, renal failure, mortality (Teixeira et al., 1997; Jin and Conti, 2002) or in a 
multiple sclerosis mouse model (Moore et al., 2006). 
The present study aims to determine the regional distribution in rat brain of the four PDE4B 
splice variants. The possible involvement of cAMP through PDE4B in inflammation prompted us 
to analyze the expression of the different PDE4 isozymes in the brain of LPS treated rats. 
MATERIALS AND METHODS 
Animal procedure was performed according to the European Union regulations (O.J. of E.C. 
L358/1 18/12/1986) and was approved by the Institutional Animal Care and Use Committee. 
Adult male Wistar rats (200-300 g; Iffa Credo, Lyon, France) used for the neuroanatomical 
localization of PDE4B splicing variants expression were decapitated and the brain was 
removed, frozen on dry ice and kept at -20 ºC.  LPS treatment was performed as follows: rats 
were injected intraperitoneally with vehicle or LPS (from Escherichia coli, serotype 055:B5, 
Sigma, St. Louis, MO, USA; 500 µg/kg of body weight) diluted in 300 µl of 0.9% sterile saline. 
Four rats were sacrificed at each of 1, 2, 3 and 4 hr post injection. Eight control rats received an 
injection of 0.9% sterile saline, and were sacrificed four at each of 2 and 3 hr post injection. 
Several oligonucleotides were synthesized for each splicing variant: PDE4B1, bp 383-427, and 
506-550, AF202732; PDE4B2 bp 418-462, 520-564, 545-589, L27058; PDE4B3 bp 476-520, 
556-600, 616-660, 700-744, U95748; PDE4B4 bp 171-215, 216-260, 264-308, AF202733. 
COX-2 mRNA oligonucleotides were complementary to bp 1848-1893, NM_017232. The mRNA 
regions for each PDE4B splice variants were chosen because they share no similarity with each 
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other. Evaluation of the oligonucleotide sequences with basic local alignment search tool of 
EMBL and GenBank databases indicated that the probes do not present any significant 
similarity with mRNAs other than their corresponding targets in the rat. The specificity of the 
autoradiographic signal obtained in the in situ hybridization histochemistry experiments was 
confirmed by performing a series of routine controls (Pompeiano et al., 1992) such as the use of 
different oligonucleotides for the same mRNA obtaining identical hybridization patterns with 
each individual probe in the entire rat brain; competition with the same unlabeled 
oligonucleotide for the non-specific hybridization signal, determination of the Tm of the hybrids, 
etc. The procedures followed for the in situ hybridization experiments have been published 
elsewhere (Reyes-Irisarri et al., 2005). The results presented in this work have been done using 
only one of the different oligonucleotides designed for each splicing form appropriately labeled 
at their 3’ end with 33P-dATP. 
A semiquantitative measure of the optical densities of the autoradiograms was conducted with 
the MCID4 and AISR computerized image analysis systems (Imaging Research Inc, St 
Catharines, Ontario, Canada). Anatomical brain structures were verified by the examination of 
cresyl violet-stained sections and identified using a rat brain atlas (Paxinos and Watson, 1998). 
For each rat, individual values of optical densities in each region were calculated as the mean of 
2 adjacent sections in both hemispheres (average of 4 measures per rat and region). The 
following regions were measured: area postrema, CA fields of the hippocampus, cerebellum, 
choroid plexus, corpus callosum, dorsal cochlear nucleus, dentate gyrus, hilus, leptomeninges, 
medial genicular nucleus, medial habenular nucleus, median eminence, organum vasculosum 
of the lamina terminalis, primary somatosensory cortex, pyramidal tract. Statistical analysis was 
performed using GraphPad Prism 4 (GraphPad Software Inc, San Diego, CA, USA) and SPSS 
v14 (SPSS Inc, Chicago, IL, USA). Analysis of data variance for all the experiments were 
performed considering the factors PDE (4 levels), brain region (13 levels) and treatment (5 
levels: control and 1, 2, 3 and 4 hours post injection). Then, the different regions were analyzed 
by factors PDE and treatment. Post hoc analysis (Bonferroni’s test) was performed for treatment 
by each PDE in the statistically affected regions. Since no significant statistical difference 
between the two groups of control rats was observed in any of the regions analyzed, we unified 
the values as a single control group.  
RESULTS AND DISCUSSION 
mRNA distribution of PDE4B splicing variants in rat brain 
We used in situ hybridization histochemistry to study the distribution of the four PDE4B 
splicing variants at various coronal levels of the rat brain (Fig. 1). Table I summarizes our 
semiquantitative measurements of the content of each mRNA in different brain regions. The 
splicing variants identified by hybridization with only one oligonucleotide each (and allways the 
same) show a coincident hybridization pattern in several brain areas, such as granular layer of 
the cerebellum and piriform cortex. In contrast they are differentially expressed in other brain 
areas, indicating a possible non-redundant role in the regulation of intracellular cAMP levels.  
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Interestingly, PDE4B1, PDE4B2 and PDE4B3 are detected in the area postrema whereas 
PDE4B4 is absent (or expressed at very low levels). This area has been implicated as a 
chemoreceptor trigger zone for emesis (Borinson H.L. and Wang, 1953; Carpenter et al., 1988). 
The emetic side effects of rolipram are well known, when used as an antidepressant, (Scott et 
al., 1991). So too are those that other PDE4 inhibitors (such as roflumilast and cilomilast) 
produce in patients treated with them for asthma or chronic obstructive pulmonary disease 
(COPD) (Spina, 2003; Chung, 2006). The fact that we found no expression of PDE4B4 mRNA 
in the rat area postrema (even though rodents do not vomit) and that it has been proposed that 
in humans PDE4B4 exon is unlikely to encode a protein (Shepherd et al., 2003), points to the 
importance of determining the expression of PDE4 splice variants in this area and  other related 
areas of the human brain. This will help to find candidate targets for specific splicing variant 
PDE4 inhibitors with no emetic side effects to treat the aforementioned diseases. 
In the hippocampal formation all four isoforms are visualized in CA2 and CA3 fields. In the 
dentate gyrus the only splicing isoform found was PDE4B2. The basic circuitry of the 
hippocampus is a trisynaptic circuit (Brown and Zador, 1990) where the sensory inputs from the 
entorhinal cortex arrive at the granule cells of the dentate gyrus, whose main output -via mossy 
fiber axons- is the pyramidal neurons of CA3, that send their Schaffer collateral axons to 
pyramidal neurons of CA1. Some of the synapses of the hippocampus display a remarkable 
form of plasticity, long-term potentiation (LTP), that could be relevant to the mnemonic functions 
of this circuitry (Brown et al., 1988), and is a leading candidate for a synaptic mechanism for 
rapid learning in mammals (Brown and Zador, 1990). This form of plasticity has been studied 
most in the mossy fiber and in the Schaffer collateral axons. Several authors (Barad et al., 
1998; Bach et al., 1999; Rose et al., 2005) suggest that rolipram could enhance hippocampus-
dependent memory tasks, and reduce cognitive decline associated with neurodegenerative and 
psychiatric diseases. These studies together with our finding that PDE4B2 is the only splicing 
variant expressed in the dentate gyrus, suggest that it could be involved in LTP regulation in the 
mossy fiber axons. The findings of Ahmed and Frey (2003) that PDE4B3 is involved in the 
regulation of LTP in the hippocampus, do not invalidate our suggestion, since there are different 
mechanisms for the two LTP systems: the mossy fibers and the Schaffer collateral inputs. 
PDE4B3 could be involved in the LTP of Schaffer collateral inputs, (which take place in the CA3 
region where all the splicing variants of PDE4B are expressed) and PDE4B2, could be involved 
in the LTP system of the mossy fibers output, which originates in the dentate gyrus, where 
PDE4B2 is the only splicing form expressed. 
Systemic administration of LPS: effects on the brain. 
In order to study the effects of short-term systemic administration of LPS on the expression 
of PDE4 isozymes in rat brain, we measured the corresponding mRNA levels 1, 2, 3 and 4 hr 
after LPS treatment in 15 brain areas (including some circumventricular organs) for the 4 
splicing variant mRNAs. In order to validate our inflammatory animal model, we analyzed COX-
2 mRNA expression in LPS-brains, since COX-2 mRNA is up-regulated in endothelial and 
perivascular cells of rat and mouse brain blood vessels after LPS administration (Cao et al., 
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1997). As expected, we found that COX-2 mRNA levels were considerably increased 2 hr after 
LPS injection in microvasculature and leptomeninges (Fig. 2). The analysis of the 
autoradiogram optical densities for the four PDE4B splicing variant mRNAs indicated a strong 
influence of the factors PDE (F= 126.750; p<0.0001) and region (F= 337.929; p<0.0001), while 
the influence of treatment was indicated by the interaction between PDE-treatment (F= 2.057; 
p<0.05). Analysis of variance for factors PDE and treatment at the different regions identifies 
OVTL, hilus, and choroid plexus as the regions where treatment effects were more consistent. 
Finally, Bonferroni’s test performed for each PDE in these regions showed an exclusively 
significant increase in mRNA expression of PDE4B2 in choroid plexus when comparing vehicle 
with 2 and 3 hours after LPS injection (p<0.01). In these animal groups mRNA presented a 
tendency to increase in the rest of the areas. 
Upregulation in the expression of several mRNAs has been reported to occur in some of the 
brain areas we have measured, such as choroid plexus, leptomeninges, and some 
circumventricular organs (organum vasculosum of the lamina terminalis, median eminence and 
area postrema) in inflammatory models. Several authors have observed an overexpression of 
CD14 (Lacroix et al., 1998), TNF-α (Nadeau and Rivest, 1999; Quan et al., 1999), COX-2 
(Breder and Saper, 1996; Lacroix and Rivest, 1998) or IKappaB-α (Quan et al., 1997) mRNAs 
in these regions after a peripheral injection of LPS. The upregulation of PDE4B2 mRNA we 
observed in the choroid plexus and circumventricular organs after LPS injection could be of 
interest, given the fact that they may be the sites where communication between peripheral 
immune system and the brain takes place. The potential role played by PDE4B in inflammation 
is suported by the work of Conti’s group done in PDE4B knockout mice (Jin and Conti, 2002; Jin 
et al., 2005). Those animals present a decreased responsiveness to LPS in many inflammatory 
cells: peripheral leukocytes and peritoneal macrophages are not able to secrete TNF-α after 
LPS stimulation. 
To conclude, we have observed a differential distribution of the four splicing variants of 
PDE4B in the rat brain and a differential regulation for one of the PDE4B splicing variants, 
PDE4B2, in an inflammatory model. Additional experiments and the development of specific 
inhibitors for this isoform will help to elucidate its implication in the inflammatory reaction. 
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Table I. Estimated densities of PDE4B splicing variable mRNAs in different regions of the rat brain 
Brain area PDE4B1 PDE4B2 PDE4B3 PDE4B4 
Cortex 
  Parietal cortex 
  Frontal cortex 
  Cingulate cortex 
  Retrospenial cortex 
  Entorhinal cortex 
Olfactory system 
  Anterior olfactory nucleus 
  Olfactory tubercle 
  Piriform cortex 
  Islands of Calleja 
  Islands of Calleja, major island 
Basal ganglia and related areas 
  Caudate-Putamen 
  Accumbens 
    Core 
    Shell 
Limbic areas 
  Ammon’s horn 
    CA1 (pyramidal cell layer) 
    CA2 (pyramidal cell layer) 
    CA3 (pyramidal cell layer) 
  Dentate gyrus 
  Hilus 
  Subiculum 
  Pre, parasubiculum 
  Amygdala 
  Lateral septal nucleus 
  Medial septal nucleus 
Thalamus and Hypothalamus 
  Medial habenular nucleus 
  Lateral habenular nucleus 
  Paraventricular thalamic nucleus 
  Ventroposterior thalamic nuclei 
  Laterodorsal thalamic nucleus 
  Mediodorsal thalamic nucleus 
  Posterior thalamic nucleus group 
  Zona incerta 
  Reticular thalamic nucleus 
  Dorsomedial hypothalamus 
  Ventromedial hypothalamus 
  Arcuate nucleus 
  Periventricular hypothalamic nucleus 
  Medial geniculate nucleus 
  Internal capsule 
Brainstem 
  Superior colliculus 
  Oculomotor nucleus 
  Pontine nucleus 
  Accessory facial nucleus 
  Facial nucleus 
  Dorsal cochlear nucleus 
  Nucleus of the solitary tract 
  Hypoglossal nucleus 
  Cuneate nucleus 
  Dorsal motor nucleus of vagus 
  Lateral reticular nucleus 
  Gracile nucleus 
  Inferior olive 
Cerebellum 
  Molecular layer 
  Granular layer 
  White matter 
  Cerebellar nuclei 
Circumventricular organs 
  Choroid plexus 


















































































































































































































































































1mRNA data are expressed as semiquantitative estimates of hybridization intensity obtained by microdensitometric 
analysis of film autoradiograms. The levels of hybridization signals are: "+++" very strong; "++" moderate; “+" weak; “-/+” 





Fig.1. Regional distribution of PDE4B splice variant mRNAs in rat brain. Film autoradiograms 
from rat rostral to caudal sections are presented, showing the hybridization pattern of PDE4B1 
(A1-A6), PDE4B2 (B1-B6), PDE4B3 (C1-C6), and PDE4B4 (D1-D6). Note the strong hybridization 
signal of PDE4B3 in white matter, and the exclusive PDE4B2 expression in dentate gyrus of the 
hippocampus. aca, anterior commissure, anterior part; AcbSh, accumbens nucleus, shell; aci, 
anterior commissure, intrabulbar part; AO, anterior olfactory nucleus; AP, area postrema; Arc, 
arcuate nucleus; CA, Ammon’s horn of hippocampus; chp, choroid plexus; cp, cerebral 
peduncle; CPu, caudate putamen (striatum); DCo, dorsal cochlear nucleus; DG, dentate gyrus; 
gcc, genu of the corpus callosum; hil, hilus; LRt, lateral reticular nucleus; ME, median 
eminence; MG: medial genicular nucleus; MHb, medial habenular nucleus; 3, oculomotor 
nucleus; Pir, piriform cortex; Pn, pontine nuclei; PV, paraventricular thalamic nucleus; py, 
pyramidal tract; S1: primary somatosensory cortex. Bar = 3mm. 
 
Fig. 2. Distribution of COX-2 mRNA in rat hippocampus from control (A) and LPS stimulated 
rats at 2h post-injection (B). Note the profound transcriptional activation (visualized as a spotlike 
mRNA signal) detected over blood vessels of the entire brain microvasculature and 
leptomeninges of LPS-injected rats. Bar = 1 mm.  
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